1. Home
  2. SMHI vs PLX Comparison

SMHI vs PLX Comparison

Compare SMHI & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEACOR Marine Holdings Inc.

SMHI

SEACOR Marine Holdings Inc.

HOLD

Current Price

$9.45

Market Cap

212.7M

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.44

Market Cap

182.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMHI
PLX
Founded
1989
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.7M
182.9M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
SMHI
PLX
Price
$9.45
$2.44
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
121.9K
569.9K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.41
N/A
EPS
N/A
0.22
Revenue
$173,783,000.00
$52,744,000.00
Revenue This Year
$1.21
$36.81
Revenue Next Year
$9.31
N/A
P/E Ratio
N/A
$10.77
Revenue Growth
N/A
N/A
52 Week Low
$5.55
$1.46
52 Week High
$9.70
$3.19

Technical Indicators

Market Signals
Indicator
SMHI
PLX
Relative Strength Index (RSI) 68.78 61.47
Support Level $6.89 $2.06
Resistance Level N/A $3.03
Average True Range (ATR) 0.39 0.10
MACD 0.17 -0.00
Stochastic Oscillator 92.41 94.68

Price Performance

Historical Comparison
SMHI
PLX

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: